Cargando…
Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia
BACKGROUND: Immune suppression is a clinical feature of chronic lymphocytic leukaemia (CLL), and patients show increased vulnerability to SARS-CoV-2 infection and suboptimal antibody responses. METHOD: We studied antibody responses in 500 patients following dual COVID-19 vaccination to assess the ma...
Autores principales: | Parry, Helen, McIlroy, Graham, Bruton, Rachel, Damery, Sarah, Tyson, Grace, Logan, Nicola, Davis, Chris, Willett, Brian, Zuo, Jianmin, Ali, Myah, Kaur, Manjit, Stephens, Christine, Brant, Dawn, Otter, Ashley, McSkeane, Tina, Rolfe, Hayley, Faustini, Sian, Richter, Alex, Lee, Sophie, Wandroo, Farooq, Shafeek, Salim, Pratt, Guy, Paneesha, Shankara, Moss, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743056/ https://www.ncbi.nlm.nih.gov/pubmed/35000597 http://dx.doi.org/10.1186/s13045-021-01219-7 |
Ejemplares similares
-
Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia
por: Parry, H., et al.
Publicado: (2021) -
NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma
por: Parry, Helen M., et al.
Publicado: (2016) -
Long-Term Ibrutinib Therapy Reverses CD8(+) T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia
por: Parry, Helen M., et al.
Publicado: (2019) -
COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia
por: Parry, Helen, et al.
Publicado: (2022) -
Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people
por: Parry, Helen, et al.
Publicado: (2022)